Will Theranos Turn the Lab Industry Upside Down?
Theranos has received much praise along with a healthy dose of skepticism in recent months
RBCC Aggressively Pursuing Personalized Medicine Opportunities in Canada
Rainbow Coral Corp. (RBCC) is taking full advantage of more research-friendly regulations.
Now Health International and Best Doctors Insurance to Create a Leading Global International Private Medical Insurance Proposition
IPMI provider Now Health International today confirms that their investor, the Primary group.
Dangerous Liaisons: Big Pharma Facing Board-level Scandals Following M&A
Why are pharma companies leaving so much to chance?
Driving Innovation  in Colonoscopy
In March 2014, medical device company, Invendo Medical, closed a US$28m financing round led by new investor Xeraya Capital
Actavis Announces Trial Results
Company reveals outcome of Topline Phase 3 Clinical Trial for Single-Dose DALVANCE' (dalbavancin) in the Treatment of ABSSSI
Resolving IP Disputes in the Pharma Industry
Papula Nevinpat was founded in 1975 and now has an 80-strong team in Finland.
Are Mobile Medical Apps Good for our Health?
The study, revealed today, looks into the use of mobile health apps.
5 Million Euros for Medical Innovation
All seven research projects are in line with the roadmap of the Dutch Top Sector.
(UK) Pharmaceutical Industry Regulation Undermines NICE Drugs Appraisal Work
Government continues to subvert the efficiency of technology.
Revolutionary New Concept of Heart Disease Threatens End of Global Statin Market
Dr. Rath Research Institute: Revolutionary new concept of heart disease threatens end of global statin market
First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients
Merrimack Pharmaceuticals, Inc. has announced updated clinical data from a multi-arm Phase 1 study of MM-141, a bispecific antibody targeting